{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:29:27Z","timestamp":1761611367523},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T00:00:00Z","timestamp":1427500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00204-015-1505-x","type":"journal-article","created":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T19:43:48Z","timestamp":1427571828000},"page":"853-862","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hepatic effects of repeated oral administration of diclofenac to hepatic cytochrome P450 reductase null (HRN\u2122) and wild-type mice"],"prefix":"10.1007","volume":"90","author":[{"given":"James A.","family":"Akingbasote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Sarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huw B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Gerry","family":"Kenna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,28]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/egh.09.32","volume":"3","author":"N Alkhouri","year":"2009","unstructured":"Alkhouri N, Dixon LJ, Feldstein AE (2009) Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev Gastroenterol Hepatol 3:445\u2013451","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1505_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0041-008X(03)00368-5","volume":"192","author":"UA Boelsterli","year":"2003","unstructured":"Boelsterli UA (2003) Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol 192:307\u2013322","journal-title":"Toxicol Appl Pharmacol"},{"key":"1505_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/138920011795101877","volume":"12","author":"UA Boelsterli","year":"2011","unstructured":"Boelsterli UA, Ramirez-Alcantara V (2011) NSAID acyl glucuronides and enteropathy. Curr Drug Metab 12:245\u2013252","journal-title":"Curr Drug Metab"},{"key":"1505_CR4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/toxsci\/kfs310","volume":"131","author":"UA Boelsterli","year":"2013","unstructured":"Boelsterli UA, Redinbo MR, Saitta KS (2013) Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies. Toxicol Sci 131:654\u2013667","journal-title":"Toxicol Sci"},{"key":"1505_CR5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0210-5705(03)70457-9","volume":"27","author":"J Claria","year":"2004","unstructured":"Claria J, Titos E (2004) Kupffer cell. Gastroenterol Hepatol 27:264\u2013273","journal-title":"Gastroenterol Hepatol"},{"key":"1505_CR6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.vascn.2004.11.006","volume":"52","author":"SH Day","year":"2005","unstructured":"Day SH, Mao A, White R, Schulz-Utermoehl T, Miller R, Beconi MG (2005) A semi-automated method for measuring the potential for protein covalent binding in drug discovery. J Pharmacol Toxicol Methods 52:278\u2013285","journal-title":"J Pharmacol Toxicol Methods"},{"key":"1505_CR7","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/bmj.284.6329.1605","volume":"284","author":"AA Dunk","year":"1982","unstructured":"Dunk AA, Walt RP, Jenkins WJ, Sherlock SS (1982) Diclofenac hepatitis. Br Med J (Clin Res Ed) 284:1605\u20131606","journal-title":"Br Med J (Clin Res Ed)"},{"key":"1505_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1289\/ehp.02110363","volume":"110","author":"CR Elcombe","year":"2002","unstructured":"Elcombe CR, Odum J, Foster JR, Stone S, Hasmall S, Soames AR, Kimber I, Ashby J (2002) Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens. Environ Health Perspect 110:363\u2013375","journal-title":"Environ Health Perspect"},{"key":"1505_CR9","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2174\/138955706778993049","volume":"6","author":"N Ferre","year":"2006","unstructured":"Ferre N, Claria J (2006) New insights into the regulation of liver inflammation and oxidative stress. Mini Rev Med Chem 6:1321\u20131330","journal-title":"Mini Rev Med Chem"},{"key":"1505_CR10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","volume":"26","author":"TJ Gan","year":"2010","unstructured":"Gan TJ (2010) Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin 26:1715\u20131731","journal-title":"Curr Med Res Opin"},{"key":"1505_CR11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00001648-199701000-00003","volume":"8","author":"SP Gutthann","year":"1997","unstructured":"Gutthann SP, Garcia Rodriguez LA, Raiford DS (1997) Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 8:18\u201324","journal-title":"Epidemiology"},{"key":"1505_CR12","doi-asserted-by":"crossref","first-page":"13480","DOI":"10.1074\/jbc.M212087200","volume":"278","author":"CJ Henderson","year":"2003","unstructured":"Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, Rosewell I, Wolf CR (2003) Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J Biol Chem 278:13480\u201313486","journal-title":"J Biol Chem"},{"key":"1505_CR13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0891-5849(01)00560-3","volume":"31","author":"EJ Hickey","year":"2001","unstructured":"Hickey EJ, Raje RR, Reid VE, Gross SM, Ray SD (2001) Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med 31:139\u2013152","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1505_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/17425255.1.1.91","volume":"1","author":"AS Kalgutkar","year":"2005","unstructured":"Kalgutkar AS, Soglia JR (2005) Minimising the potential for metabolic activation in drug discovery. Expert Opin Drug Metab Toxicol 1(1):91\u2013142 Review","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1505_CR15","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1742-4658.2011.08432.x","volume":"279","author":"G Lorbek","year":"2012","unstructured":"Lorbek G, Lewinska M, Rozman D (2012) Cytochrome P450s in the synthesis of cholesterol and bile acids-from mouse models to human diseases. FEBS J 279:1516\u20131533","journal-title":"FEBS J"},{"issue":"4","key":"1505_CR16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1021\/tx960190k","volume":"10","author":"G Miyamoto","year":"1997","unstructured":"Miyamoto G, Zahid N, Uetrecht JP (1997) Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid. Chem Res Toxicol 10(4):414\u2013419","journal-title":"Chem Res Toxicol"},{"key":"1505_CR17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/gast.1997.v112.pm9024292","volume":"112","author":"H Mizuno","year":"1997","unstructured":"Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M (1997) Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112:387\u2013397","journal-title":"Gastroenterology"},{"key":"1505_CR18","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1021\/pr0700448","volume":"6","author":"DM Mutch","year":"2007","unstructured":"Mutch DM, Klocke B, Morrison P, Murray CA, Henderson CJ, Seifert M, Williamson G (2007) The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism. J Proteome Res 6:3976\u20133984","journal-title":"J Proteome Res"},{"key":"1505_CR19","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3748\/wjg.v20.i9.2168","volume":"20","author":"B-J Park","year":"2014","unstructured":"Park B-J, Lee Y-J, Lee H-L (2014) Chronic liver inflammation: clinical implications beyond alcoholic liver disease. World J Gastroenterol 20:2168\u20132175","journal-title":"World J Gastroenterol"},{"issue":"21","key":"1505_CR20","doi-asserted-by":"crossref","first-page":"8300","DOI":"10.1021\/es050794n","volume":"39","author":"LA Perez-Estrada","year":"2005","unstructured":"Perez-Estrada LA, Malato S, Gernjak W, Aguera A, Thurman EM, Ferrer I, Fernandez-Alba AR (2005) Photo-fenton degradation of diclofenac: identification of main intermediates and degradation pathway. Environ Sci Technol 39(21):8300\u20138306","journal-title":"Environ Sci Technol"},{"key":"1505_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/00498254.2011.607196","volume":"42","author":"K Pickup","year":"2012","unstructured":"Pickup K, Gavin A, Jones HB, Karlsson E, Page C, Ratcliffe K, Sarda S, Schulz-Utermoehl T, Wilson I (2012) The hepatic reductase null mouse as a model for exploring hepatic conjugation of xenobiotics: application to the metabolism of diclofenac. Xenobiotica 42:195\u2013205","journal-title":"Xenobiotica"},{"key":"1505_CR22","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1096\/fj.04-2753fje","volume":"19","author":"A Planaguma","year":"2005","unstructured":"Planaguma A, Claria J, Miquel R, Lopez-Parra M, Titos E, Masferrer JL, Rodes V, Arroyo J (2005) The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. Faseb J 19:1120\u20131122","journal-title":"Faseb J"},{"key":"1505_CR23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/gut.32.11.1381","volume":"32","author":"P Purcell","year":"1991","unstructured":"Purcell P, Henry D, Melville G (1991) Diclofenac hepatitis. Gut 32:1381\u20131385","journal-title":"Gut"},{"key":"1505_CR24","doi-asserted-by":"crossref","first-page":"G990","DOI":"10.1152\/ajpgi.00219.2009","volume":"297","author":"V Ramirez-Alcantara","year":"2009","unstructured":"Ramirez-Alcantara V, LoGuidice A, Boelsterli UA (2009) Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP00125 in a mouse model of NSAID-associated enterophathy. Am J Physiol Gastrointest Liver Physiol 297:G990\u2013G998","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1505_CR25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1365-2141.1996.d01-1947.x","volume":"95","author":"A Salama","year":"1996","unstructured":"Salama A, Kroll H, Wittmann G, Mueller-Eckhardt C (1996) Diclofenac-induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug-dependent antibodies. Br J Haematol 95:640\u2013644","journal-title":"Br J Haematol"},{"key":"1505_CR26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00498254.2011.607865","volume":"42","author":"S Sarda","year":"2012","unstructured":"Sarda S, Page C, Pickup K, Schulz-Utermoehl T, Wilson I (2012) Diclofenac metabolism in the mouse: novel in vivo metabolites identified by high performance liquid chromatography coupled to linear ion trap mass spectrometry. Xenobiotica 42:179\u2013194","journal-title":"Xenobiotica"},{"key":"1505_CR27","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0016-5085(98)70026-5","volume":"115","author":"S Seitz","year":"1998","unstructured":"Seitz S, Boelsterli UA (1998) Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. Gastroenterology 115:1476\u20131482","journal-title":"Gastroenterology"},{"issue":"1","key":"1505_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007691-200302000-00001","volume":"25","author":"M Shipkova","year":"2003","unstructured":"Shipkova M, Armstrong VW, Oellerich M, Wieland E (2003) Acyl glucuronide drug metabolites: toxicological and analytical implications. Ther Drug Monit 25(1):1\u201316","journal-title":"Ther Drug Monit"},{"key":"1505_CR29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.taap.2007.09.017","volume":"226","author":"M Stiborova","year":"2008","unstructured":"Stiborova M, Arlt VM, Henderson CJ, Wolf CR, Kotrbova V, Moserova M, Hudecek J, Phillips DH, Frei E (2008) Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse. Toxicol Appl Pharmacol 226:318\u2013327","journal-title":"Toxicol Appl Pharmacol"},{"key":"1505_CR30","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1124\/dmd.109.028860","volume":"37","author":"T Usui","year":"2009","unstructured":"Usui T, Mise M, Hashizume T, Yabuki M, Komuro S (2009) Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins. Drug Metab Dispos 37:2383\u20132392","journal-title":"Drug Metab Dispos"},{"key":"1505_CR31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1042\/BJ20042087","volume":"388","author":"XJ Wang","year":"2005","unstructured":"Wang XJ, Chamberlain M, Vassieva O, Henderson CJ, Wolf CR (2005) Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice. Biochem J 388:857\u2013867","journal-title":"Biochem J"},{"key":"1505_CR32","first-page":"300","volume":"27","author":"MD Wheeler","year":"2003","unstructured":"Wheeler MD (2003) Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res Health 27:300\u2013306","journal-title":"Alcohol Res Health"},{"key":"1505_CR33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1124\/jpet.112.198077","volume":"343","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Zhang QY (2012) Role of intestinal cytochrome P450 enzymes in diclofenac-induced toxicity in the small intestine. J Pharmacol Exp Ther 343:362\u2013370","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1505-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-015-1505-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1505-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T10:38:45Z","timestamp":1566470325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-015-1505-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,28]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1007\/s00204-015-1505-x","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,28]]}}}